Controlled extension stent
US-2018125684-A1 · May 10, 2018 · US
US11992425B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11992425-B2 |
| Application number | US-202016832300-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 27, 2020 |
| Priority date | Mar 29, 2019 |
| Publication date | May 28, 2024 |
| Grant date | May 28, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A structure is provided comprising a number of surfaces 10, 20 joined together with an adhesive 30, said structure being configured to reshape upon at least partial degradation of the adhesive 30. Related method and uses are further provided.
Opening claim text (preview).
The invention claimed is: 1. A structure, comprising: a plurality of surfaces; and an adhesive layer, as an Atomic Layer Deposition (ALD) coating layer of thickness 0.1-100 nm on all surfaces of the structure, wherein the plurality of surfaces are joined together by the adhesive layer in a first configuration having a collapsed shape, wherein the structure in the first configuration bears a mechanical load resulting from the adhesive layer joining said plurality of surfaces together and forming the collapsed shape, and wherein the adhesive layer is configured to at least partially degrade and thereby permit the plurality of surfaces to detach from one another and release the mechanical load, the structure configured so that when the mechanical load is released the structure reshapes itself from the collapsed shape into a second configuration having an original shape corresponding to a shape the structure had prior to the surfaces being joined together by the adhesive layer. 2. The structure of claim 1 , wherein the adhesive layer is biocompatible and/or biodegradable. 3. The structure of claim 1 , configured as a medical device. 4. The structure of claim 1 , configured as an implantable medical device. 5. The structure of claim 1 , configured as a stent. 6. The structure of claim 1 , configured for a gradual release of the mechanical load by modulating a degradation rate of the adhesive layer. 7. The structure of claim 1 , configured to release at least one chemical substance upon being reshaped due to at least partial degradation of the adhesive layer. 8. The structure of claim 7 , wherein the chemical substance comprises at least one pharmaceutically active agent. 9. The structure of claim 1 , wherein the adhesive layer comprises at least one ALD-deposited coating layer made of any of aluminium oxide (Al 2 O 3 ), magnesium oxide (MgO), and silicon dioxide (SiO 2 ). 10. The structure of claim 1 , formed of a mesh wire. 11. The structure of claim 1 , wherein the pre-applied mechanical load is a spring load. 12. A method for manufacturing a structure, comprising: obtaining a structure having a plurality of surfaces, said structure configured to have an original shape; applying an adhesive to all surfaces of the structure by Atomic Layer Deposition (ALD); and joining said surfaces together with the adhesive so that said structure assumes a collapsed shape different from said original shape, wherein the structure is configured to bear a mechanical load when in the collapsed shape and held by the adhesive, and wherein the adhesive is configured to at least partially degrade in order to permit release of the mechanical load and thereby cause the collapsed structure to reshape and acquire the original shape that the structure had prior to the surfaces being joined together. 13. A method for delivering at least one pharmaceutically active agent into the body, wherein said at least one pharmaceutically active agent is provided in a structure comprising a plurality of surfaces joined together with an adhesive provided in the form of a coating layer applied by Atomic Layer Deposition (ALD), wherein said structure is configured to release said pharmaceutically active agent upon at least partial degradation of the adhesive in the body. 14. The method of claim 13 , wherein the structure is configured to release said at least one pharmaceutically active agent upon being reshaped by virtue of at least partial degradation of the adhesive in the body. 15. A medical device comprising the structure of claim 1 . 16. The medical device of claim 15 , wherein the medical device is implantable.
Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (stent-grafts for tubular structures of the body other than blood vessels A61F2/04; stent-grafts for blood vessels A61F2/07) · CPC title
bioabsorbable · CPC title
using adhesives · CPC title
Designing or manufacturing processes · CPC title
made from both resorbable and non-resorbable prosthetic parts, e.g. adjacent parts · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.